These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 740579)
1. Effects of progestogens on serum lipids in the post-menopause. Maddock J Postgrad Med J; 1978; 54 Suppl 2():38-41. PubMed ID: 740579 [TBL] [Abstract][Full Text] [Related]
2. Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric. Aylward M Postgrad Med J; 1978; 54 Suppl 2():31-7. PubMed ID: 740578 [TBL] [Abstract][Full Text] [Related]
3. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations. Aylward M; Maddock J; Parker A; Protheroe DA; Ward A Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584 [TBL] [Abstract][Full Text] [Related]
4. The effect of injectable contraceptive on lipid metabolism in women. Kandeel KM; Nayel SA; Abaza MS Biomed Biochim Acta; 1984; 43(1):111-5. PubMed ID: 6721873 [TBL] [Abstract][Full Text] [Related]
5. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women. Paterson ME; Sturdee DW; Moore B; Whitehead TP Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948 [TBL] [Abstract][Full Text] [Related]
6. Effect of castration and long-term oral oestrogen therapy with oestriol succinate on serum lipids. Punnonen R; Rauramo L Ann Chir Gynaecol; 1976; 65(3):216-9. PubMed ID: 962291 [TBL] [Abstract][Full Text] [Related]
7. Alterations in blood sugar, protein, and lipid levels in Indian women by norethisterone enanthate. Chaudhuri C; Bhowmik T; Mukherjea M Int J Fertil; 1987; 32(3):240-4. PubMed ID: 2885291 [TBL] [Abstract][Full Text] [Related]
8. Effect of a sequential oestrogen-progestin therapy on the plasma level of oestrogens and lipids in post-menopausal women. Lillienberg L; Adlercreutz H; Svanborg A Acta Endocrinol (Copenh); 1979 Oct; 92(2):319-29. PubMed ID: 494994 [No Abstract] [Full Text] [Related]
9. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909 [TBL] [Abstract][Full Text] [Related]
10. Lipids and lipoproteins in women after oophorectomy and the response to oestrogen therapy. Notelovitz M; Gudat JC; Ware MD; Dougherty MC Br J Obstet Gynaecol; 1983 Feb; 90(2):171-7. PubMed ID: 6297536 [TBL] [Abstract][Full Text] [Related]
11. Effect of piperazine oestrone sulphate on serum lipids and lipoproteins in menopausal women. Isaacs AJ; Havard CW Acta Endocrinol (Copenh); 1977 May; 85(1):143-50. PubMed ID: 577072 [TBL] [Abstract][Full Text] [Related]
12. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. Ylikorkala O; Lim P; Caubel P Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559 [TBL] [Abstract][Full Text] [Related]
13. Positive effects of conjugated equine estrogen on triglyceride metabolism in oophorectomized women based on a stratification analysis of pretreatment values. Hashimoto K; Nozaki M; Nakano H Fertil Steril; 2004 Apr; 81(4):1041-6. PubMed ID: 15066461 [TBL] [Abstract][Full Text] [Related]
14. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women. Barnes RB; Roy S; Lobo RA Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832 [TBL] [Abstract][Full Text] [Related]
15. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids. Rozenberg S; Ylikorkala O; Arrenbrecht S Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385 [TBL] [Abstract][Full Text] [Related]
16. Serum bile acids and lipids during treatment of climacteric symptoms with natural oestrogen--progestin combinations. Ylöstalo P; Heikkinen J; Mäentausta O; Jänne O Maturitas; 1981 Mar; 3(1):21-4. PubMed ID: 7253932 [TBL] [Abstract][Full Text] [Related]
17. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia. Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207 [TBL] [Abstract][Full Text] [Related]
18. The effect of sequential mestranol-norethisterone on the circulating lipid levels of pre- and post-menopausal women, and its possible significance. Magnani HN; Moore B Postgrad Med J; 1976; 52 Suppl 6():55-9. PubMed ID: 981121 [No Abstract] [Full Text] [Related]
19. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use. Brynhildsen J; Hammar M Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536 [TBL] [Abstract][Full Text] [Related]
20. Effect of oestriol succinate on serum lipids. Saarikoski S; Niemelä A; Jokela H; Pystynen P Maturitas; 1981 Dec; 3(3-4):235-9. PubMed ID: 7334934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]